OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Hylenex recombinant

hyaluronidase human

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Hylenex recombinant
Proper name
hyaluronidase human
Licence type
351(a)
BLA number
021859
Applicant
Halozyme Therapeutics, Inc.
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
150UNITS/ML Injection Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous Single-Dose Vial Rx December 2, 2005

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity